A-RAF Antibody (YA614)

(Synonyms: ARAF1, PKS, PKS2, ARAF, Serine/threonine-protein kinase A-Raf, Proto-oncogene A-Raf, Proto-oncogene A-Raf-1, Proto-oncogene Pks)
Customer Review

Based on 1 Customer Validation

A-RAF Antibody (YA614) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to A-RAF.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, ICC/IF, IHC-P, FC

  • Reactivity :

    Human, Mouse

  • Formulation:

    Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
FC Info
FC: Flow Cytometry
Dilution Ratio 1:500-1:2000 1:50-1:200 1:50-1:200 1:50-1:100

Product Details

Description

A-RAF Antibody (YA614) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to A-RAF.

  • Host Rabbit
  • Clonality Recombinant,Monoclonal
  • Species Reactivity
    Human, Mouse
  • Observed Molecular Weight
    Observed band size: 68 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 68 kDa
Species Reactivity Database
Immunogen

Synthetic peptide corresponding to Human A-RAF.AA range:146-310.

Sensitivity

Endogenous

Purification

Protein A affinity purified.

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

RRID

AB_3102263

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for A-RAF Antibody (YA614)
    Western blot analysis of extracts from Hela (lane 2, 20ug), A549 (lane 3, 20ug), K562 (lane 4, 20ug) and NIH/3T3 (lane 5, 20ug) using A-RAF Antibody (HY-P80018). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST at 4°C overnight. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80993, 1/10,000) was used in 5% non-fat milk in TBST for 2 hour at room temperature. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HY-P8001, 1/10,000) was used for 1 hour at room temperature.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human prostate cancer using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human prostate using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human thyroid using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human cervical cancer using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human tonsil using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Immunohistochemical analysis of paraffin-embedded human colon cancer using A-RAF antibody. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH 9.0) for 14 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with TBST, and then probed with the primary antibody (HY-P80018, 1/100) for 30 minutes at room temperature. The detection was performed using Polymer HRP-conjugated Goat Anti-Mouse/Rabbit lgG(H&L) secondary antibody (HY-P83652). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
  • Experimental Validation Results for A-RAF Antibody (YA614)
    Flow cytometric analysis of 1X106 HeLa cells labeling A-RAF Antibody(HY-P80018, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/100 dilution for an hour at 4℃. AF488-conjugated Goat Anti-Rabbit IgG H&L (HY-P8002) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Rabbit IgG Isotype Control (HY-P80879, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

Background

  • Function

    A-Raf (ARAF) is a member of the RAF serine/threonine kinase family and functions as a downstream effector of RAS that initiates signaling through the RAF-MEK-ERK mitogen-activated protein kinase (MAPK) cascade, thereby regulating cellular growth, proliferation, and differentiation[1][2]. Mechanistically, activated A-Raf phosphorylates MEK1/2 and contributes to ERK activation, placing ARAF at a critical upstream position in MAPK pathway regulation[1][2]. Dysregulation of the RAS-RAF-MEK-ERK signaling network is strongly associated with oncogenesis, and recurrent activating alterations in ARAF have been identified in multiple cancer types, supporting its relevance in tumor biology and experimental cancer models[3][4]. Compared with the related RAF isoforms BRAF and CRAF, A-Raf displays distinct biochemical properties, including substantially lower kinase activity toward MEK and tighter regulatory control, which may contribute to isoform-specific signaling outputs and biological functions[3][2]. This distinction is particularly important because oncogenic activation mechanisms differ among RAF family members, and mutations equivalent to highly transforming BRAF variants do not necessarily produce the same biological effects in ARAF[2]. In disease models, ARAF dimerization has been shown to promote MAPK pathway activation and tumor cell invasion, highlighting its functional contribution beyond its comparatively weak catalytic activity[4]. For experimental and therapeutic applications, RAF inhibitors remain important tools for interrogating ARAF-dependent signaling; however, several type II RAF inhibitors exhibit reduced potency against A-Raf relative to other RAF isoforms, emphasizing the need to consider isoform selectivity when designing mechanistic studies or targeted therapeutic strategies[1][5].

  • Expression


    Tissue_specificity:Mainly distributed in urogenital tissues

  • Subunit

    Interacts with TH1L/NELFD

  • SwissProt ID

    P10398

  • Gene ID
    369 [NCBI]
  • Synonyms

    ARAF1, PKS, PKS2, ARAF, Serine/threonine-protein kinase A-Raf, Proto-oncogene A-Raf, Proto-oncogene A-Raf-1, Proto-oncogene Pks

  • Research Field

    Signal Transduction

References

A-RAF Antibody (YA614) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00